Riskpilot← Back to searchSign inGet full accessOJ NMR ApS
APSActiveCVR 39709023Ingridsvej 23Manufacture of irradiation, electromedical and electrotherapeutic equipment · NACE 2660Est. 20181 employees
Revenue 2025
DKK 249K
0% vs 2024
EBITDA margin
-8.9%
+12% vs 2024
Equity ratio
-38.9%
Financial strength
Net profit 2025
DKK -61K
+31% vs 2024
| Revenue | DKK 249K | +0% |
| EBITDA | DKK -22K | +12% |
| Net profit | DKK -61K | +31% |
| Total assets | DKK 2,7M | +4% |
| Equity | DKK -1,1M | -6% |
| Employees | 1 | — |
Legal name
OJ NMR ApS
CVR number
39709023
Legal form
Anpartsselskab
NACE code
2660 · Manufacture of irradiation, electromedical and electrotherapeutic equipment
Founded
6. juli 2018
Share capital
DKK 50.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er direkte eller via besiddelse af kapitalandele i andre selskaber at drive virksomhed med udvikling, handel med og investering i NMR teknologi samt anden virksomhed, der efter direktionens skøn er forbundet dermed.
Address
Ingridsvej 23
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | -14 | 160 | 436 | 324 | 349 | 248 | 249 |
| Staff expenses | -0 | -301 | -279 | -270 | -262 | -273 | -272 |
| EBITDA | -14 | -141 | 157 | 53 | 87 | -25 | -22 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -14 | -141 | 157 | 53 | 87 | -25 | -22 |
| Net financials | -9 | 17 | -2.121 | -12 | -14 | -89 | -57 |
| Profit before tax | -23 | -124 | -895 | 41 | 73 | -115 | -79 |
| Tax | -0 | -0 | 7 | 9 | 16 | -25 | -17 |
| Net profit | -23 | -124 | -902 | 32 | 57 | -89 | -61 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total assets | 3.231 | 3.769 | 2.896 | 2.701 | 2.587 | 2.630 | 2.724 |
| Equity | 27 | -97 | -998 | -966 | -909 | -999 | -1.060 |
| Long-term debt | 0 | 33 | 43 | 0 | 0 | 0 | 44 |
| Short-term debt | 3.204 | 3.832 | 3.852 | 3.668 | 3.496 | 3.629 | 3.784 |
| Total debt | 3.204 | 3.866 | 3.895 | 3.668 | 3.496 | 3.629 | 3.784 |
EBITDA margin
-8.9%
This company
15.8%
Market median
-156% vs market
20192025
Equity ratio
-38.9%
This company
38.2%
Market median
-202% vs market
20192025
Return on equity
-6141500.0%
This company
18.4%
Market median
-33377817% vs market
20192025
Net profit margin
-24.6%
This company
8.1%
Market median
-404% vs market
20192025
Asset turnover
0.09×
This company
1.12×
Market median
-92% vs market
20192025
Debt / equity
3.57×
This company
0.62×
Market median
-476% vs market
20192025
- Annual report 2025Filed via CVR / Virk · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via CVR / Virk · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via CVR / Virk · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via CVR / Virk · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via CVR / Virk · Period 2020-05-01 – 2021-04-30
- Annual report 2020Filed via CVR / Virk · Period 2019-05-01 – 2020-04-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-06 – 2019-04-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
ON Management | Management | 2018 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
OJ NMR Holding ApS | Company | 100.0% | 100.0% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
OJ NMR Holding ApS
OJ NMR ApS Board members of OJ NMR ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ole Nørgaard Jensen | Management | 0 companies |